Guilford, CT, United States of America

Chris Conrad

USPTO Granted Patents = 7 

 

 

Average Co-Inventor Count = 7.9

ph-index = 3

Forward Citations = 15(Granted Patents)


Location History:

  • Mount Vernon, NY (US) (2019)
  • Guilford, CT (US) (2019 - 2022)

Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: **The Innovative Mind of Chris Conrad: Advancing Cancer Treatment**

Introduction

Chris Conrad, an accomplished inventor based in Guilford, CT, has made significant contributions to the field of cancer treatment. With a total of seven patents to his name, he has dedicated his career to developing innovative therapies that harness the potential of apilimod, a compound that shows promise in combating various types of cancer.

Latest Patents

Among his most recent patents, Chris has developed compositions and methods for using apilimod in the treatment of cancer. His latest innovations include:

1. **Apilimod compositions and methods for using same** - This invention relates to methods for treating cancer with apilimod and various related compositions.

2. **Apilimod compositions and methods for using same in the treatment of renal cancer** - This disclosure details methodologies for treating renal cancer using apilimod and associated compositions.

Career Highlights

Throughout his career, Chris has held key positions at notable companies such as Ai Therapeutics, Inc. and Lam Therapeutics, Inc. His work has not only advanced our understanding of cancer treatment but also positioned him as a leader in pharmaceutical innovation. His commitment to improving patient outcomes through targeted therapies is commendable.

Collaborations

Chris has also collaborated with talented individuals in the industry, including coworkers Neil Beeharry and Sean Landrette. These partnerships have undoubtedly enriched his research and allowed for the sharing of diverse ideas and expertise in the development of groundbreaking treatments.

Conclusion

In conclusion, Chris Conrad's contributions to the field of cancer treatment through his inventions showcase his role as a dedicated innovator. With a strong portfolio of patents focusing on the applications of apilimod, he continues to pave the way for transformative therapies that aim to improve the lives of cancer patients. His work exemplifies the spirit of innovation and underscores the importance of persistent research in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…